ArticleSisli Etfal Hastanesi tip bulteni2026
Intracytoplasmic Sperm Injection Outcomes Using Epididymal Sperm Obtained by Percutaneous Aspiration: An 11-Year Single-Center Experience.
Article in Sisli Etfal Hastanesi tip bulteni, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Percutaneous epididymal sperm aspiration (PESA) is a minimally invasive surgical sperm retrieval technique used in patients unable to provide ejaculated spermatozoa. This study aimed to evaluate fertilization, clinical pregnancy, and live birth outcomes following intracytoplasmic sperm injection (ICSI) using epididymal sperm obtained via PESA over an 11-year period at a single tertiary referral center. Methods: This retrospective cohort study analyzed 63 PESA-ICSI cycles performed in 46 male patients between January 2015 and December 2025. Indications for PESA included obstructive azoospermia (n=13 cycles) and medically refractory ejaculatory dysfunction (n=50 cycles). Outcomes were evaluated both at the cycle level and independently per embryo transfer (ET) procedure. Comparative analyses were performed according to PESA indication, embryo developmental stage at transfer, and transfer type. Results: Sperm retrieval was completely successful in all 63 cycles (100%). Of 498 mature (MII) oocytes injected, normal fertilization (2PN) was achieved in 268, yielding an oocyte-level fertilization rate of 53.8%. Total fertilization failure occurred in only one cycle (1.6%). Embryo transfer was performed in 57 cycles, resulting in 68 individual transfer procedures (42 fresh and 26 frozen-thawed). The overall clinical pregnancy rate was 39.7% (25/63) per initiated cycle and 36.8% (25/68) per ET procedure. The overall live birth rate was 33.3% (21/63) per initiated cycle and 30.9% (21/68) per ET procedure. No statistically significant differences were observed between cleavage-stage and blastocyst-stage transfers with respect to clinical pregnancy (p=0.615) or live birth outcomes (p=1.000). No major procedural complications were recorded. Conclusion: PESA combined with ICSI provides favorable reproductive outcomes with a low rate of total fertilization failure. These results were achieved despite a cohort characterized by diminished ovarian reserve and diverse male infertility etiologies. The high sperm retrieval success rate and consistent clinical outcomes support PESA as a reliable and effective sperm retrieval technique in contemporary assisted reproductive practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.